Venus Remedies Ltd Performance
Day's Low
Day's High
₹303.3Day's Price Range₹311.952 Week's Low
52 Week's High
₹281.152-Week Price Range₹430
| Returns % | |
| 1 Month Return | + 0.54 % |
| 3 Month Return | -9.27 % |
| 1 Year Return | -22.69 % |
| Market Stats | |
| Previous Close | ₹305.70 |
| Open | ₹303.30 |
| Volume | 8,958.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹408.63Cr |
Venus Remedies Ltd Key Statistics
| P/E Ratio | 18.48 |
| PEG Ratio | -7.36 |
| Market Cap | ₹408.63 Cr |
| P/B Ratio | 0.86 |
| EPS | 21.31 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 6.18 |
Venus Remedies Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹408.63 Cr | 248.16% | 0.54 | ₹28 Cr | ₹601 Cr | |
| NA | ₹126.36 Cr | 43.48% | 0.51 | NA | NA | |
| NA | ₹4,527.03 Cr | 131.24% | 0.70 | ₹86 Cr | ₹806 Cr | |
| NA | ₹14.67 Cr | 16.08% | 0.69 | NA | NA | |
| BUY | ₹14,378.67 Cr | 75.83% | 0.63 | ₹405 Cr | ₹4,506 Cr |
About Venus Remedies Ltd
Share Price: ₹306.55 per share as on 27 Dec, 2024 04:01 PM
Market Capitalisation: ₹408.63Cr as of today
Revenue: ₹167.45Cr as on September 2024 (Q3 24)
Net Profit: ₹3.51Cr as on September 2024 (Q3 24)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
| Organisation | Venus Remedies Ltd |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Venus Remedies Ltd
Venus Remedies Gains After Lung Cancer Drug Approval - 09 Dec, 2024
Venus Remedies shares surged 6% after receiving marketing authorization for Pemetrexed 500mg, a lung cancer treatment, in the Philippines. Despite a 64.69% decline in net profit for Q3 2024, the company aims to strengthen its presence in the Southeast Asian pharmaceutical market.Venus Remedies Gains Approval for Lung Cancer Drug - 06 Dec, 2024
Venus Remedies Ltd's shares rose significantly after the company secured marketing authorization for Pemetrexed 500mg, enhancing its presence in the Southeast Asian pharmaceutical market.
Insights on Venus Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 1.22 Cr → 3.51 Cr (in ₹), with an average increase of 65.2% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.06% to 1.18% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 110.2 Cr → 178.03 Cr (in ₹), with an average increase of 38.1% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.6% return, outperforming this stock by 74.2%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 131.9% return, outperforming this stock by 149.0%
NEGATIVE IMPACTPrice Dip
In the last 1 year, VENUSREM stock has moved down by -22.7%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 57.03% to 56.91% in Sep 2024 quarter
Venus Remedies Ltd Financials
Venus Remedies Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 41.76% | 0.00 | |
| Foreign Institutions | 1.18% | 10.91 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 56.91% | ||
| Others | 0.15% |
Venus Remedies Ltd Key Indicators
Venus Remedies Ltd Valuation
Venus Remedies Ltd in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (18.48x)
December 26, 2024
Industry (56.67x)
December 26, 2024
Highest (21.70x)
December 28, 2023
Venus Remedies Ltd Earnings and Dividends
Venus Remedies Ltd Earnings Results
Venus Remedies Ltd’s net profit fell -64.69% since last year same period to ₹3.51Cr in the Q2 2024-2025. On a quarterly growth basis, Venus Remedies Ltd has generated 187.7% jump in its net profits since last 3-months.
Read More about Earnings Results
Venus Remedies Ltd Technicals Summary
Bearish
Neutral
Bullish
Venus Remedies Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Venus Remedies Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Venus Remedies Ltd shares.
Venus Remedies Ltd (VENUSREM) share price today is ₹306.55
Venus Remedies Ltd is listed on NSE
Venus Remedies Ltd is listed on BSE
- Today’s highest price of Venus Remedies Ltd is ₹311.9.
- Today’s lowest price of Venus Remedies Ltd is ₹303.3.
PE Ratio of Venus Remedies Ltd is 18.48
PE ratio = Venus Remedies Ltd Market price per share / Venus Remedies Ltd Earnings per share
Today’s traded volume of Venus Remedies Ltd(VENUSREM) is 8,958.00.
Today’s market capitalisation of Venus Remedies Ltd(VENUSREM) is ₹408.63Cr.
| Venus Remedies Ltd(VENUSREM | Price |
|---|---|
52 Week High | ₹430 |
52 Week Low | ₹281.1 |
Venus Remedies Ltd(VENUSREM) share price is ₹306.55. It is down -28.71% from its 52 Week High price of ₹430
Venus Remedies Ltd(VENUSREM) share price is ₹306.55. It is up 9.05% from its 52 Week Low price of ₹281.1
| Venus Remedies Ltd(VENUSREM | Returns |
|---|---|
1 Day Returns | 0.85% |
1 Month Returns | 0.54% |
3 Month Returns | -9.27% |
1 Year Returns | -22.69% |